» Articles » PMID: 36004350

Bibliometric Insights in Advances of Papillary Thyroid Microcarcinoma: Research situation, Hot Points, and Global Trends

Overview
Specialty Endocrinology
Date 2022 Aug 25
PMID 36004350
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Thyroid cancer has been on the rise over the last decade. Papillary thyroid microcarcinoma (PTMC) accounts for more than half of all thyroid cancers. Micropapillary carcinoma of the thyroid is a common but non-fatal form of thyroid cancer. To better comprehend, nearly two decades of scientific outputs were analyzed and summarized using bibliometric methods in this study.

Methods: Approximately 1098 publications from 2000 and 2021 were included in WoS database through systematic retrieval. The general information was characterized, and developmental skeleton and research frontiers were explored. CiteSpace, VOSviewer, and R, Tableau were used to evaluate and visualize the results.

Results: A total of 1098 publications from across 75 countries were identified. The annual number of publications showed an increasing trend in the past 21 years. China, Korea, the United States of America (USA), Italy, and Japan made remarkable contributions to the research of PTMC. Thyroid was the most productive journal. Miyauchi Akira published maximum articles. The utmost productive institution was the University of Ulsan. Risk stratification, active surveillance, and thermal ablation garnered the attention of researchers leading to novel approaches in the clinical diagnosis and treatment of micropapillary thyroid carcinoma.

Conclusions: This bibliometric study provides a comprehensive analysis of global productivity, collaboration, and research hotspots within PTMC field, which will aid in directing research toward PTMC in the coming years.

Citing Articles

Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis.

Song B, Lin Z, Feng C, Zhao X, Teng W Front Endocrinol (Lausanne). 2023; 14:1252389.

PMID: 37795362 PMC: 10546338. DOI: 10.3389/fendo.2023.1252389.


A bibliometric analysis based on Web of Science from 2012 to 2021: Current situation, hot spots, and global trends of medullary thyroid carcinoma.

Li R, Wang Y, Zhao Z, Li X, Liu Z Front Oncol. 2023; 13:1119915.

PMID: 36959786 PMC: 10029728. DOI: 10.3389/fonc.2023.1119915.

References
1.
Liu X, Qu S, Liu R, Sheng C, Shi X, Zhu G . TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer. J Clin Endocrinol Metab. 2014; 99(6):E1130-6. PMC: 4037723. DOI: 10.1210/jc.2013-4048. View

2.
Orloff L, Noel J, Stack Jr B, Russell M, Angelos P, Baek J . Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section.... Head Neck. 2021; 44(3):633-660. DOI: 10.1002/hed.26960. View

3.
Cho B, Choi H, Park Y, Lim J, Ahn H, Lee E . Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid. 2013; 23(7):797-804. PMC: 3704118. DOI: 10.1089/thy.2012.0329. View

4.
Markantes G, Tsochatzis S, Panagopoulos K, Melachrinou M, Kyriazopoulou V, Markou K . A shift to more targeted thyroidectomies increased the detection of thyroid cancer and in particular low-risk papillary tumors in Southwestern Greece the decade 2007 to 2016. Laryngoscope Investig Otolaryngol. 2020; 5(6):1260-1265. PMC: 7752045. DOI: 10.1002/lio2.504. View

5.
Su H, Li Y . Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a meta-analysis. Braz J Otorhinolaryngol. 2018; 85(2):237-243. PMC: 9452245. DOI: 10.1016/j.bjorl.2018.05.004. View